MedPath

Studie naar hysteroscopische behandeling van littekendefecten na sectio bij patienten met abnormaal uterien bloedverlies.

Recruiting
Conditions
abnormal uterine bleedingcesarean scar defect hysteroscopic resectionabnormaal uterien bloedverlieslittekendefect na sectiohysteroscopie
Registration Number
NL-OMON26833
Lead Sponsor
S. Veersema, gynaecoloog St Antonius Ziekenhuis, NieuwegeinL.F. van der Voet, gynaecoloog Deventer Ziekenhuis, DeventerProf H.A.M. Brollman, gynaecoloog VU Medisch Centrum Amsterdam
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
22
Inclusion Criteria

Patients with a cesarean scar defect and abnormal uterine bleeding.

Exclusion Criteria

1. Pregnancy;

2. Wish for pregnancy in future;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease in days of bloodloss/spotting<br>(pictorial chart).
Secondary Outcome Measures
NameTimeMethod
1. Quality of life by SF -36 questionaire;<br /><br>2. Complications;<br /><br>3. Decrease in dysmenorrhoe by VAS score;<br /><br>4. Satisfaction patients with therapy by questionaire.
© Copyright 2025. All Rights Reserved by MedPath